Research to develop diagnostic and therapeutic methods for cancer of the renal pelvis and ureter

Not Applicable

• Conditions: Cancer of the renal pelvis and ureter; renal pelvis cancer, ureteral cancer; D014516, D007682

• Registration Number: JPRN-jRCT1030220502
• Lead Sponsor: Hayakawa Nozomi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-12-09
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Patients who have visited the outpatient urology clinic, who are at least 20 years old, and whose urine can be collected.

Exclusion Criteria

1) Patients undergoing treatment for malignant diseases in other departments
2) Patients who are judged by the investigator to be unsuitable as subjects
3) Patients who have indicated that they will not cooperate in this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Exosomes extracted from urine samples will be analyzed using the ExoScreen method to evaluate differences in expression of specific exosomes between patients with renal pelvis or ureteral cancer and others.

Secondary Outcome Measures

Name	Time	Method
In immunochemical staining of surgical specimens, the expression of target substances in cancer tissue, mainly nucleic acids and proteins including miRNAs in this study, will be compared with that in noncancer tissue.